New brain bleed surgery within 8 hours could change stroke care
NCT ID NCT04434807
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 34 times
Summary
This trial tests whether removing a brain clot with a small, minimally invasive surgery within 8 hours of a stroke helps people recover better than standard medical care. About 240 adults with large brain bleeds will be randomly assigned to surgery or standard treatment. The goal is to see if more people can live independently at 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gold Coast University Hospital
RECRUITINGSouthport, Queensland, 4215, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
John Hunter Hospital
RECRUITINGNewcastle, New South Wales, 2305, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Liverpool Hospital
RECRUITINGSydney, New South Wales, 2170, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Monash Medical Centre
NOT_YET_RECRUITINGMelbourne, Victoria, 3168, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prince of Wales Hospital
NOT_YET_RECRUITINGSydney, New South Wales, 2031, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Princess Alexandra Hospital
NOT_YET_RECRUITINGBrisbane, Queensland, 4102, Australia
Contact
-
Royal Prince Alfred Hospital
NOT_YET_RECRUITINGSydney, New South Wales, 2050, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Austin Hospital
NOT_YET_RECRUITINGMelbourne, Victoria, 3084, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Royal Brisbane and Women's Hospital
RECRUITINGBrisbane, Queensland, 4029, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Royal Melbourne Hospital
RECRUITINGParkville, Victoria, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Westmead Hospital
NOT_YET_RECRUITINGSydney, New South Wales, 2145, Australia
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Minimally invasive hematoma evacuation using the Aurora surgiscope and evacuator
What this could lead to
If successful, this could offer a safer, more effective way to treat severe brain bleeds, potentially reducing long-term disability.
What could go wrong
This is a mid-stage trial with 240-434 participants, so results are not yet proven. Surgery within 8 hours carries risks like infection or rebleeding, and may not improve outcomes over standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.